In vitro evaluation of S-25930 and S-25932, two new quinolones, against aerobic gram-negative isolates from cancer patients.

類似資料

• In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.
  著者:: Rolston, K V, 等
  出版事項: (1987)
• In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.
  著者:: Rolston, K V, 等
  出版事項: (1993)
• Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
  著者:: Dholakia, N, 等
  出版事項: (1994)
• In vitro activity of sparfloxacin (CI-978; AT-4140) against clinical isolates from cancer patients.
  著者:: Rolston, K V, 等
  出版事項: (1990)
• In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.
  著者:: Rudin, J E, 等
  出版事項: (1984)